How Cuba Became a Biopharma Juggernaut
More recently, the CIMAvax-EGF vaccine for lung cancer became the first Cuban biopharmaceutical product to carry out clinical trials on American soil.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
